High-quality statin trials support the 2013 American College of Cardiology/American Heart Association cholesterol guidelines after the HOPE-3 trial (heart outcomes prevention evaluation-3): MESA (The multiethnic study of atherosclerosis)

Martin Bødtker Mortensen, Matthew Budoff, Dong Li, Khurram Nasir, Michael J. Blaha, Veit Sandfort, Carlos Jose Rodriguez, Pamela Ouyang, Erling Falk

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1863-1865
Number of pages3
JournalCirculation
Volume136
Issue number19
DOIs
StatePublished - Jun 23 2017

Keywords

  • Cardiovascular diseases
  • Guideline
  • Hydroxymethylglutaryl-CoA reductase inhibitors
  • Lipoproteins
  • Primary prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint Dive into the research topics of 'High-quality statin trials support the 2013 American College of Cardiology/American Heart Association cholesterol guidelines after the HOPE-3 trial (heart outcomes prevention evaluation-3): MESA (The multiethnic study of atherosclerosis)'. Together they form a unique fingerprint.

Cite this